Home
>
National Drug Code (NDC)
>
Rizatriptan Benzoate
Rizatriptan Benzoate - 65862-625-90 - (Rizatriptan Benzoate)
Drug Information of Rizatriptan Benzoate
| Product NDC: | 65862-625 |
| Proprietary Name: | Rizatriptan Benzoate |
| Non Proprietary Name: | Rizatriptan Benzoate |
| Active Ingredient(s): | 5 mg/1 & nbsp; Rizatriptan Benzoate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Rizatriptan Benzoate
| Product NDC: | 65862-625 |
| Labeler Name: | Aurobindo Pharma Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA203062 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130701 |
Package Information of Rizatriptan Benzoate
| Package NDC: | 65862-625-90 |
| Package Description: | 3 BLISTER PACK in 1 CARTON (65862-625-90) > 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-03) |
NDC Information of Rizatriptan Benzoate
| NDC Code | 65862-625-90 |
| Proprietary Name | Rizatriptan Benzoate |
| Package Description | 3 BLISTER PACK in 1 CARTON (65862-625-90) > 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-03) |
| Product NDC | 65862-625 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Rizatriptan Benzoate |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20130701 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | RIZATRIPTAN BENZOATE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
